Practical and clinical benefits of radioimmunotherapy lead to advantages in cost-effectiveness in the treatment of patients with non-Hodgkin's lymphoma

Nucl Med Commun. 2006 Oct;27(10):753-6. doi: 10.1097/01.mnm.0000224467.74545.27.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Insurance, Health
  • Lymphoma, Non-Hodgkin / therapy*
  • Radioimmunotherapy / economics*
  • Radioimmunotherapy / methods*
  • Safety
  • Treatment Outcome
  • Yttrium Radioisotopes / therapeutic use

Substances

  • Yttrium Radioisotopes